S'abonner

The Extent of Myocardial Injury During Prolonged Targeted Temperature Management After Out-of-Hospital Cardiac Arrest - 18/04/17

Doi : 10.1016/j.amjmed.2016.06.047 
Anders Morten Grejs, MD a, b, c, , Jakob Gjedsted, MD, PhD b, c, Kristian Thygesen, MD, DMSc d, Jens Flensted Lassen, MD, PhD e, Bodil Steen Rasmussen, MD, PhD f, g, Anni Nørgaard Jeppesen, MD a, b, c, Christophe Henri Valdemar Duez, MD a, c, Eldar Søreide, MD, PhD h, i, Hans Kirkegaard, MD, DMSc, PhD a, c
a Research Center for Emergency Medicine, Aarhus University Hospital, Denmark 
b Department of Anesthesiology and Intensive Care Medicine, Aarhus University Hospital, Denmark 
c Department of Clinical Medicine, Aarhus University, Denmark 
d Department of Cardiology, Aarhus University Hospital, Denmark 
e Department of Cardiology, Rigshospitalet, University Hospital of Copenhagen, Denmark 
f Department of Anesthesiology and Intensive Care Medicine, Aalborg University, Denmark 
g Department of Clinical Medicine, Aalborg University, Denmark 
h Department of Anesthesiology and Intensive Care, Stavanger University Hospital, Norway 
i Department of Clinical Medicine, University of Bergen, Norway 

Requests for reprints should be addressed to Anders Morten Grejs, MD, Department of Anesthesiology and Intensive Care Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200 Aarhus N, Denmark.Department of Anesthesiology and Intensive Care MedicineAarhus University HospitalPalle Juul-Jensens Boulevard 99Aarhus NDK-8200Denmark

Abstract

Aim

The aim of this study is to evaluate the extent of myocardial injury by cardiac biomarkers during prolonged targeted temperature management of 24 hours vs 48 hours after out-of-hospital cardiac arrest.

Methods

This randomized Scandinavian multicenter study compares the extent of myocardial injury quantified by area under the curve (AUC) of cardiac biomarkers during prolonged targeted temperature management at 33°C ± 1°C of 24 hours and 48 hours, respectively. Through a period of 2.5 years, 161 comatose out-of-hospital cardiac arrest patients were randomized to targeted temperature management for 24 hours (n = 77) or 48 hours (n = 84). The AUC was calculated using both high-sensitivity cardiac troponin T (hs-cTnTAUC) and creatine kinase-myocardial band (CK-MBAUC) that were based upon measurements of these biomarkers every 6 hours upon admission until 96 hours after reaching target temperature.

Results

The median hs-cTnTAUC of 33,827 ng/L/h (interquartile range [IQR] 11,366-117,690) of targeted temperature management at 24 hours did not differ significantly from that of 28,973 ng/L/h (IQR 10,656-163,655) at 48 hours. In contrast, the median CK-MBAUC of 1829 μg/L/h (IQR 800-6799) during targeted temperature management at 24 hours was significantly lower than that of 2428 μg/L/h (IQR 1163-10,906) within targeted temperature management at 48 hours, P <.05.

Conclusion

This study of comatose out-of-hospital cardiac arrest survivors showed no difference between the extents of myocardial injury estimated by hs-cTnTAUC of prolonged targeted temperature management of 48 hours vs 24 hours, although the CK-MBAUC was significantly higher during 48 hours vs 24 hours. Hence, it seems unlikely that the duration of targeted temperature management has a beneficial effect on the extent of myocardial injury after out-of-hospital cardiac arrest, and may even have a worsening effect.

Le texte complet de cet article est disponible en PDF.

Keywords : Body temperature regulation, CK-MB, Heart arrest, Induced mild hypothermia, Out-of-hospital cardiac arrest, Troponin T, Targeted temperature management


Plan


 ClinicalTrials.gov Identifier: NCT02066753.
 Funding: Aarhus University Hospital, Aalborg University Hospital, Stavanger University Hospital, The Danish Society of Anesthesiology and Intensive Care Medicine, The Scandinavian Society of Anesthesiology and Intensive Care Medicine, Foundation of 1870 and the Aase and Ejnar Danielsen Foundation financially supported this study. The sponsors had no influence on the analysis, the manuscript, or the choice of publishing journal. None of the contributors are from the pharmaceutical industry.
 Conflict of Interest: All authors declare no conflict of interest.
 Authorship: All authors had access to the data and participated in writing the manuscript according to the Vancouver protocol.


© 2016  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 130 - N° 1

P. 37-46 - janvier 2017 Retour au numéro
Article précédent Article précédent
  • Treading Lightly: ST-Segment Elevation on an Exercise Electrocardiogram
  • Bradley D. Stauber, Sandhya Venugopal, Ezra A. Amsterdam
| Article suivant Article suivant
  • An Educational and Administrative Intervention to Promote Rational Laboratory Test Ordering on an Academic General Medicine Service
  • Bradley M. Wertheim, Andrew J. Aguirre, Roby P. Bhattacharyya, John Chorba, Ashutosh P. Jadhav, Vanessa B. Kerry, Eric A. Macklin, Gabriela Motyckova, Shveta Raju, Kent Lewandrowski, Daniel P. Hunt, Douglas E. Wright

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.